Records containing: Psoriasis

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2021-08-02
  A Phase 2b Randomized, Double-blind, Placebo Controlled, Multi-center 12-week Study With an Additional 40-week Follow-up Assessment of Efficacy, Safety and Tolerability of M1095 in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis
• CLINICAL_TRIALS study record update · 2021-07-23
  SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE
• CLINICAL_TRIALS study record update · 2021-07-21
  The Efficacy and Safety of Topical Methotrexate Microemulsion in Combination With Excimer Light and Narrow Band-ultraviolet B in the Treatment of Plaque Psoriasis
• CLINICAL_TRIALS study record update · 2021-07-20
  An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail Psoriasis
• CLINICAL_TRIALS study record update · 2021-07-20
  A Randomized, Double-blind, Vehicle Controlled Study of the Safety and Efficacy of Topical DRM02 in Subjects With Plaque Psoriasis
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2021-07-20
  Induction of Regulatory t Cells by Low Dose IL2 in Autoimmune and Inflammatory Diseases: a Transnosographic Approach
• CLINICAL_TRIALS study record update · 2021-07-20
  A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study to Determine the Efficacy, Safety and Tolerability of Once Daily Oral ZPL-3893787- 18 (30 mg) Administered for 12 Weeks in Adult Subjects With Moderate to Severe Plaque Psoriasis
• CLINICAL_TRIALS study record update · 2021-07-16
  Effects of UVB Excimer Laser on Serum Inflammatory Markers in Patients With Psoriasis
• CLINICAL_TRIALS study record update · 2021-07-13
  A Multicenter, Randomized, Open Label, Efficacy Assessor-Blinded Study of Risankizumab Compared to Secukinumab for the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy
• CLINICAL_TRIALS study record update · 2021-07-08
  A Phase 1/2a Single Dose and 28-day Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream 0.5% and 0.15% in Adults With Mild to Moderate Chronic Plaque Psoriasis
• CLINICAL_TRIALS study record update · 2021-07-02
  VOLTAIRE-X: Pharmacokinetics, Safety, Immunogenicity and Efficacy of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis: a Randomized, Double-blind, Parallel-arm, Multiple-dose, Active Comparator Trial
• CLINICAL_TRIALS study record update · 2021-07-02
  Impact of Red and Processed Meat and Fibre Intake on Treatment Outcome Among Patients With Chronic Inflammatory Diseases: Protocol for a Prospective Cohort Study on Prognostic Factors and Personalised Medicine
• CLINICAL_TRIALS study record update · 2021-06-07
  A Prospective Post Market Clinical Follow-up Investigation With Epaderm® Cream to Confirm Performance and Safety Parameters
• CLINICAL_TRIALS study record update · 2021-06-04
  Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions
• CLINICAL_TRIALS study record update · 2021-05-27
  An Exploratory, Multicenter, Observational Study to Examine RNA Biomarkers of Psoriasis Subjects Through the Application of the Mindera Kit Part 2 (STAMP-2).
• CLINICAL_TRIALS study record update · 2021-05-19
  Phase 1 Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative Colitis
• CLINICAL_TRIALS study record update · 2021-05-17
  A Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Mild to Moderate Plaque Psoriasis
• CLINICAL_TRIALS study record update · 2021-05-11
  Plaque Psoriasis: Usability of the Risankizumab Autoinjector Combination Product in Adults With Moderate to Severe Psoriasis
• CLINICAL_TRIALS study record update · 2021-05-11
  A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-157 in Healthy Volunteers and in Subjects With Chronic Plaque Psoriasis
• CLINICAL_TRIALS study record update · 2021-05-11
  A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-to-Severe Plaque Psoriasis (AFFIRM)
• CLINICAL_TRIALS study record update · 2021-05-10
  A Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Moderate to Severe Psoriasis
• CLINICAL_TRIALS study record update · 2021-04-19
  Etude Pilote Exploratoire Des capacités Pronostiques de Rechute et Des Facteurs de Persistance de la mémoire Lymphocytaire T Dans Les Maladies Inflammatoires Chroniques
• CLINICAL_TRIALS study record update · 2021-04-01
  Efficacy of Dexamethasone Iontophoresis in Psoriasis
• CLINICAL_TRIALS study record update · 2021-03-30
  A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
• CLINICAL_TRIALS study record update · 2021-03-23
  International Multi-center Comparative Randomized Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis